JNJ-42756493 is an inhibitor of FGFR-1, 2, 3 and 4 with nanomolar affinity for targeted therapy

Abstract

Manuscrito. -- 1 h.; papel; folio. -- Fondo Universidad de Salamanca; secci贸n Claustros; serie Borradores de claustros. -- Buena conservaci贸n. -- Fechas: 11/08/1788

    Similar works